We Accelerate Discovery

You are here


Program Snapshot

The NIH is partnering with the U.S. Food and Drug Administration (FDA) and the Defense Advanced Research Projects Agency (DARPA) to advance the field of regulatory science, a specialized research area that aims to improve assessment of experimental therapies, preventives, and diagnostics. The Common Fund’s Regulatory Science program is fostering the development, evaluation and availability of new or improved tools, methods, standards, and applied science that support a better understanding and improved evaluation of product safety, quality, effectiveness, and manufacturing throughout the product life cycle. 

During the initial phase of the program, launched in fiscal year 2010, four new research awards in high priority areas of regulatory science were supported. Expansion of the program in FY 2012 focuses on developing new cell-based technologies, called microsystems, to predict more accurately drug safety and efficacy in humans. 

Read more…

Program Highlights



Regulatory Science FDA

Modeling the Female Reproductive Tract in 3-D: The Birth of EVATAR™

National Center for Advancing Translational Sciences (NCATS) site: Tissue Chip for Drug Screening program

Meet Chip! 

Chip is an interactive model that can help you learn about the innovative developments from the Tissue Chip program.

NCATS Meet Chip

For more information about the Tissue Chip program, watch the new video  from the National Center for Advancing Translational Sciences (NCATS).


Up to Top